Pages that link to "Q71328286"

The following pages link to Evaluating the efficacy of new inotropic agents (Q71328286):

Displaying 15 items.

• Review of randomized trials of digoxin therapy in patients with chronic heart failure (Q36303971) (← links)
• Phosphodiesterase inhibition by new cardiotonic agents: mechanism of action and possible clinical relevance in the therapy of congestive heart failure (Q38682363) (← links)
• Is inotropic therapy appropriate for patients with chronic congestive heart failure? Or is the digitalis leaf withering? (Q38951649) (← links)
• Selective updates on mechanisms of action of positive inotropic agents (Q39148010) (← links)
• Beneficial effects of a Ca2 sensitizer, MCI-154, on the myocardial oxygen consumption-cardiac output relation in patients with left ventricular dysfunction after myocardial infarction: comparison with dobutamine and phosphodiesterase inhibitor (Q42550877) (← links)
• Survival of patients with severe congestive heart failure treated with oral milrinone (Q43488442) (← links)
• Evaluation of long-term oral levodopa therapy in chronic congestive heart failure. (Q54397028) (← links)
• Multicenter trial of dynamic cardiomyoplasty for chronic heart failure (Q58853962) (← links)
• Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators (Q68964230) (← links)
• Sustained inotropic effects of a new cardiotonic agent. OPC-8212 in patients with chronic heart failure (Q69489279) (← links)
• Management of arrhythmias in heart failure (Q69495372) (← links)
• Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure (Q69549004) (← links)
• Cardiac drugs: new inotropes (Q69804529) (← links)
• Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure (Q70032077) (← links)
• Pharmacologic management of heart failure: positive inotropic agents (Q72748511) (← links)